AS703569

AS703569 · EMD Serono

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AS703569, covering 2013-10-22 to 2014-01-30. Get the full timeline:

Most recent: Clinical Trial Update: AS703569 Phase I in Patients With Solid Tumours [Phase 1]